These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 9700596)
21. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Stanley CA; Hale DE; Coates PM; Hall CL; Corkey BE; Yang W; Kelley RI; Gonzales EL; Williamson JR; Baker L Pediatr Res; 1983 Nov; 17(11):877-84. PubMed ID: 6646897 [TBL] [Abstract][Full Text] [Related]
22. Milder childhood form of very long-chain acyl-CoA dehydrogenase deficiency in a 6-year-old Japanese boy. Doi T; Abo W; Tateno M; Hayashi K; Hori T; Nakada T; Fukao T; Takahashi Y; Terada N Eur J Pediatr; 2000 Dec; 159(12):908-11. PubMed ID: 11131350 [TBL] [Abstract][Full Text] [Related]
23. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method. Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814 [TBL] [Abstract][Full Text] [Related]
24. Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-term L-carnitine supplementation. Treem WR; Stanley CA; Goodman SI J Inherit Metab Dis; 1989; 12(2):112-9. PubMed ID: 2502671 [TBL] [Abstract][Full Text] [Related]
25. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study. MacDonald A; Webster R; Whitlock M; Gerrard A; Daly A; Preece MA; Evans S; Ashmore C; Chakrapani A; Vijay S; Santra S J Pediatr Endocrinol Metab; 2018 Mar; 31(3):297-304. PubMed ID: 29425111 [TBL] [Abstract][Full Text] [Related]
26. Slc22a5 haploinsufficiency does not aggravate the phenotype of the long-chain acyl-CoA dehydrogenase KO mouse. Ranea-Robles P; Yu C; van Vlies N; Vaz FM; Houten SM J Inherit Metab Dis; 2020 May; 43(3):486-495. PubMed ID: 31845336 [TBL] [Abstract][Full Text] [Related]
27. Detection and quantitation of acylcarnitines in plasma and blood spots from patients with inborn errors of fatty acid oxidation. Schmidt-Sommerfeld E; Penn D; Duran M; Rinaldo P; Bennett MJ; Santer R; Stanley CA Prog Clin Biol Res; 1992; 375():355-62. PubMed ID: 1438381 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids. Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520 [TBL] [Abstract][Full Text] [Related]
29. Rhabdomyolysis in early-onset very long-chain acyl-CoA dehydrogenase deficiency despite normal glucose after fasting. Engbers HM; Dorland L; de Sain MG; Eskes PF; Visser G J Inherit Metab Dis; 2005; 28(6):1151-2. PubMed ID: 16435213 [TBL] [Abstract][Full Text] [Related]
30. Carnitine supplementation induces long-chain acylcarnitine production--studies in the VLCAD-deficient mouse. Liebig M; Gyenes M; Brauers G; Ruiter JP; Wendel U; Mayatepek E; Strauss AW; Wanders RJ; Spiekerkoetter U J Inherit Metab Dis; 2006; 29(2-3):343-4. PubMed ID: 16763898 [TBL] [Abstract][Full Text] [Related]
31. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders. Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821 [TBL] [Abstract][Full Text] [Related]
32. Decreased fasting free fatty acids with L-carnitine in children with carnitine deficiency. Schwenk WF; Hale DE; Haymond MW Pediatr Res; 1988 May; 23(5):491-4. PubMed ID: 3290828 [TBL] [Abstract][Full Text] [Related]
33. Acylcarnitine removal in a patient with acyl-CoA beta-oxidation deficiency disorder: effect of L-carnitine therapy and starvation. Fontaine M; Briand G; Vallée L; Ricart G; Degand P; Divry P; Vianey-Saban C; Vamecq J Clin Chim Acta; 1996 Aug; 252(2):109-22. PubMed ID: 8853559 [TBL] [Abstract][Full Text] [Related]
36. The effect of long-term oral L-carnitine administration on insulin sensitivity, glucose disposal, plasma concentrations of leptin and acylcarnitines, and urinary acylcarnitine excretion in warmblood horses. Kranenburg LC; Westermann CM; de Sain-van der Velden MG; de Graaf-Roelfsema E; Buyse J; Janssens GP; van den Broek J; van der Kolk JH Vet Q; 2014; 34(2):85-91. PubMed ID: 24893614 [TBL] [Abstract][Full Text] [Related]
37. [A case of very long chain acyl-CoA dehydrogenase deficiency diagnosed due to a trigger of hyperemesis gravidarum during pregnancy]. Shiraishi W; Tateishi T; Hayashida S; Tajima G; Tsumura M; Isobe N Rinsho Shinkeigaku; 2023 Oct; 63(10):656-660. PubMed ID: 37779023 [TBL] [Abstract][Full Text] [Related]
38. Long-term dietary effects on substrate selection and muscle fiber type in very-long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice. Tucci S; Pearson S; Herebian D; Spiekerkoetter U Biochim Biophys Acta; 2013 Apr; 1832(4):509-16. PubMed ID: 23313579 [TBL] [Abstract][Full Text] [Related]
39. Quantitative measurement of total and free 3-hydroxy fatty acids in serum or plasma samples: short-chain 3-hydroxy fatty acids are not esterified. Jones PM; Burlina AB; Bennett MJ J Inherit Metab Dis; 2000 Nov; 23(7):745-50. PubMed ID: 11117435 [TBL] [Abstract][Full Text] [Related]
40. A profile of cerebral and hepatic carnitine, ammonia, and energy metabolism in a model of organic aciduria: BALB/cByJ mouse with short-chain acyl-CoA dehydrogenase deficiency. Qureshi IA; Ratnakumari L; Michalak A; Giguère R; Cyr D; Butterworth RF Biochem Med Metab Biol; 1993 Oct; 50(2):145-58. PubMed ID: 8260192 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]